Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611000978965Phase 4Completed
Phase 4, open-label trial of fentanyl (2 arms), sponsored by Cortical Dynamics. Primary endpoint: BAR monitor ability to detect varying anesthetic levels. Started Dec 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611000978965.